
NeurAxis, Inc. (NRXS) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript
Seeking Alpha
Published: Sep 15, 2026, 03:21 PM
SA Transcripts 162.21K Followers Follow NeurAxis, Inc. ( NRXS ) IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 September 15, 2026 9:00 AM EDT Company Participants Brian Carrico - President, CEO & Director Presentation Unknown Analyst Good morning, and thank you for joining us for the iAccess Alpha Virtual Best Ideas Fall Investment Conference. IAccess Alpha hosts 4 virtual investor conferences annually focused on small and microcap public companies. Many of the companies that participate in our events are introduced to us through recommendations from investors and industry professionals. We'd like to give a special thanks to all of the investors who have continued to recommend ideas and participate in our conferences. Your involvement is a critical part of what makes these events possible, and we sincerely appreciate your continued support. Our next conference will be the iAccess Alpha Virtual Best Ideas Winter Investment Conference taking place on December 8 and 9, 2026. Thank you again for joining us. We hope you find today's presentations informative. Now let's begin with our first presenting company, Neur, Inc. [Operator Instructions] I'd now like to turn the floor over to today's host, Brian Carrico, President and Chief Executive Officer of NeurAxis, Inc. Please go ahead. Brian Carrico President, CEO & Director Thank you. My name is Brian Carrico, CEO of NeurAxis. I appreciate everyone joining today. As the host mentioned, we are NeurAxis. We've been public since August of 2023, so just over 3 years, and I look forward to presenting today for about 20 minutes and opening it up for questions for the last 10 minutes. So who are we? So for those of you who are new, and I hope many on the call are new, we are a first-to-market growth stage med tech company. We're focused on neuromodulation therapies for chronic and debilitating conditions in GI, specifically from disorders in
Source: Seeking Alpha
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.